SynthesisFrontiers in pharmacology2026

Dual BAFF/APRIL inhibition with telitacicept in systemic lupus erythematosus and IgA nephropathy: pharmacological rationale, clinical efficacy, and safety on female fertility preservation.

Hongzhu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.